Dr. Obaid bin Saad Al-Abdali Al-Shareef, member of the Saudi Shoura Council 

Dr. Obaid bin Saad Al-Abdali Al-Shareef, member of the Saudi Shoura Council 
Dr. Obaid bin Saad Al-Abdali Al-Shareef
Updated 20 April 2019

Dr. Obaid bin Saad Al-Abdali Al-Shareef, member of the Saudi Shoura Council 

Dr. Obaid bin Saad Al-Abdali Al-Shareef, member of the Saudi Shoura Council 

Dr. Obaid bin Saad Al-Abdali Al-Shareef has been a member of the Shoura Council since December 2016.

He attained his bachelor’s degree in business from King Abdul Aziz University in Jeddah in 1986, his MBA in advertising from Cardiff University in 1990, and his Ph.D. in marketing from the University of Manchester in 1996.

He has been a member of the advisory board of the faculty of business at Prince Sattam bin Abdul Aziz University in Al-Kharj since October 2018.

Al-Shareef served as adviser to the deputy minister of higher education from September 2011 to May 2015.

He was a professor at the King Fahd University of Petroleum & Minerals from October 1991 to September 2015.

The Shoura Council, represented by Al-Shareef, recently took part in a meeting in Russia on sustainable development, water and public health in Asia.

The meeting aims to support the implementation of the objectives of sustainable development, as well as drafting a resolution on water and public health, in Asia, and another to adopt providing measures to stimulate green financing.


Saudi Arabia’s first COVID-19 vaccine set for clinical trials

Saudi Arabia’s first COVID-19 vaccine set for clinical trials
Updated 25 min 6 sec ago

Saudi Arabia’s first COVID-19 vaccine set for clinical trials

Saudi Arabia’s first COVID-19 vaccine set for clinical trials
  • It will go through rigorous testing and several trial stages before it is approved for use by the Saudi Food and Drug Authority

RIYADH: Preclinical studies on the first Saudi vaccine against COVID-19 have been completed.

Professor of epidemiology Dr. Iman Almansour, who heads the team of researchers working on the vaccine at the Institute for Research and Medical Consultations (IRMC), affiliated with Imam Abdulrahman Bin Faisal University (IAU), confirmed to Arab News on Friday that the studies were complete, and said clinical trials would begin as soon as “the proper approvals” had been given.

She did not specify when that is expected to happen.

The Ministry of Education is financing the team’s project. The team’s research paper has been published in the peer-reviewed journal Pharmaceuticals.

According to the published paper, the vaccine has so far proven effective, when used on animals, in eliciting antibodies that will target the virus. “The vaccine is given to the body to build protein inside cells, which stimulate the body to produce immunity specific to the S antigen,” Dr. Almansour explained.

Dr. Turki Almugaiteeb, director of Healthcare and Life Sciences at RPD Innovations, which runs the National Vaccine and Biomanufacturing Center, told Arab News: “There is a great focus on the results of medical research because of the pandemic. Research can play a great role in developing a vaccine that can be adopted and further developed in the future. We can say that the Kingdom has a strong infrastructure, which can help produce and manufacture a national vaccine.”

Both Almugaiteeb and Almansour stressed that the experimental vaccine will need to go through rigorous testing and several trial stages before it is approved for use by the Saudi Food and Drug Authority.

Prof. Nasser Al-Aqeeli, the deputy minister of education for research and innovation, said the ministry supported programs at the Kingdom’s universities with more than SR500 million ($133.3 million) in 2020.